Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37K Buy
1,320
+443
+51% +$9.78K ﹤0.01% 1793
2026
Q1
$13K Buy
877
+337
+62% +$4.95K ﹤0.01% 2050
2025
Q4
$7K Sell
540
-225
-29% -$3.32K ﹤0.01% 2193
2025
Q3
$12K Buy
765
+425
+125% +$6.85K ﹤0.01% 1896
2025
Q2
$5K Sell
340
-206
-38% -$3.12K ﹤0.01% 2037
2025
Q1
$10K Buy
546
+50
+10% +$1.09K ﹤0.01% 1785
2024
Q4
$12K Buy
496
+235
+90% +$6.56K ﹤0.01% 1698
2024
Q3
$7K Buy
261
+80
+44% +$2.26K ﹤0.01% 1808
2024
Q2
$4K Hold
181
﹤0.01% 1784
2024
Q1
$4K Hold
181
﹤0.01% 1793
2023
Q4
$4K Buy
181
+125
+223% +$2.52K ﹤0.01% 1847
2023
Q3
$1K Sell
56
-54
-49% -$1.06K ﹤0.01% 2114
2023
Q2
$2K Sell
110
-1,405
-93% -$28.3K ﹤0.01% 2067
2023
Q1
$29K Buy
1,515
+15
+1% +$288 ﹤0.01% 1331
2022
Q4
$26K Buy
+1,500
New +$26.6K ﹤0.01% 1261

Other funds holding RXO

Bessemer Group's RXO Position: Q2 2026 in Review

Bessemer Group increased its RXO (RXO) stake by 51% in Q2 2026, buying an estimated $9.78K and bringing the position to 1,320 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #1793.

Bessemer Group first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Bessemer Group held 1,320 shares of RXO worth $37K as of Q2 2026.
  • Bessemer Group bought 443 RXO shares in Q2 2026, an estimated $9.78K.
  • RXO made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1793 holding.
  • Bessemer Group first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.